Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Semi-annual Business Results
December 22, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
December 22, 2003
- NEW PRODUCTS
December 22, 2003
- Virtual Heart Should Improve Drug Development Success Rates: Dr Noble
December 22, 2003
- REGULATORY NEWS IN BRIEF
December 15, 2003
- Taisho, HP Japan Create First PMS Support System for OTC Drugs
December 15, 2003
- Approval of 3 New Drugs Incl. Olmes Recommended
December 15, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 15, 2003
- Semi-annual Business Results
December 15, 2003
- Semi-annual Business Results
December 15, 2003
- Kraft: Double-digit Growth in Sales, Profits
December 15, 2003
- VITAL-NET: Sales Price Reductions Hurt Profits
December 15, 2003
- Cawachi: Operating Profits Up 0.8%
December 15, 2003
- Atol: Sales, Profits Down
December 15, 2003
- Yomeishu: Sales Slip 5.4%
December 15, 2003
- Ohki: Consolidated Sales Grow 8.2%
December 15, 2003
- OTC NEWS IN BRIEF
December 15, 2003
- Ando Chemical Works: Sales Down 8.2% to \12.4 Bil.
December 15, 2003
- GSK Completes PI Study on Ono's New HIV Drug in the US
December 15, 2003
- Nippon Chemiphar: Drug Sales Fall 9.9% to \7,738 Mil.
December 15, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…